Sagent Pharmaceuticals, a provider of pharmaceuticals to the hospital market, has named Frank Harmon as executive vice president, global operations. In this newly created role, Mr. Harmon will oversee Sagent’s global operations including product development, R&D, manufacturing, supply chain, regulatory and global alliance management, with oversight support of quality assurance.

“Mr. Harmon joins Sagent at an exciting time as we begin to execute against our Triple E strategy which is focused on accelerating our growth and enhancing our operational performance,” said Allan Oberman, chief executive officer, Sagent. “Frank’s extensive experience in pharmaceutical manufacturing and operations, with a proven history of success operating multiple injectable facilities, improving margins and managing complicated supply chains, will play an important role in accelerating our long-term growth trajectory and capitalizing on the favorable market opportunities that we see as critical to long-term value creation.”

Mr. Harmon has close to 40 years of pharmaceutical operations experience with companies including Fresenius Kabi, Cardinal Health, and Aventis-Behring (formerly Centeon LLC). Most recently, he served as vice president, operations of Nesher Pharmaceuticals, a wholly owned subsidiary of Zydus Pharmaceuticals, where he was responsible for all manufacturing and contract packaging operations for generic solid dose and oral liquid products.